If IL-6 signaling was more relevant to PP development than to PV, such data would provide an explanation to clinical evidence that efficacy rates of TNF-alpha inhibitors in PP are lower as compared to PV [14]. The gene discussed is TNF; the disease is acquired polycythemia vera.